Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.

Hong CS, Muller L, Boyiadzis M, Whiteside TL.

PLoS One. 2014 Aug 5;9(8):e103310. doi: 10.1371/journal.pone.0103310. eCollection 2014.

2.

Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.

Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M.

Haematologica. 2011 Sep;96(9):1302-9. doi: 10.3324/haematol.2010.039743. Epub 2011 May 23.

4.

Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).

Whiteside TL.

Biochem Soc Trans. 2013 Feb 1;41(1):245-51. doi: 10.1042/BST20120265. Review.

5.

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.

Rao J, Xu DR, Zheng FM, Long ZJ, Huang SS, Wu X, Zhou WH, Huang RW, Liu Q.

J Transl Med. 2011 May 19;9:71. doi: 10.1186/1479-5876-9-71.

6.

CD117/CD34 expression in leukemic blasts.

Wells SJ, Bray RA, Stempora LL, Farhi DC.

Am J Clin Pathol. 1996 Aug;106(2):192-5.

PMID:
8712172
7.

RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.

Jajosky AN, Coad JE, Vos JA, Martin KH, Senft JR, Wenger SL, Gibson LF.

Stem Cells Transl Med. 2014 Jul;3(7):836-48. doi: 10.5966/sctm.2013-0193. Epub 2014 May 22.

8.

Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.

Bradbury DA, Russell NH.

Br J Haematol. 1995 Oct;91(2):374-9.

PMID:
8547078
9.

Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?

Boyiadzis M, Whiteside TL.

Expert Rev Mol Diagn. 2016 Jun;16(6):623-9. doi: 10.1080/14737159.2016.1174578. Epub 2016 Apr 25. Review.

10.
11.

High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.

Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M.

Pediatr Hematol Oncol. 2011 Mar;28(2):91-9. doi: 10.3109/08880018.2010.528171. Epub 2011 Jan 8.

PMID:
21214408
12.

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.

Siegler U, Kalberer CP, Nowbakht P, Sendelov S, Meyer-Monard S, Wodnar-Filipowicz A.

Leukemia. 2005 Dec;19(12):2215-22.

PMID:
16224486
13.

Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.

Zarovni N, Corrado A, Guazzi P, Zocco D, Lari E, Radano G, Muhhina J, Fondelli C, Gavrilova J, Chiesi A.

Methods. 2015 Oct 1;87:46-58. doi: 10.1016/j.ymeth.2015.05.028. Epub 2015 Jun 2.

PMID:
26044649
14.

Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia.

Hong CS, Muller L, Whiteside TL, Boyiadzis M.

Front Immunol. 2014 Apr 10;5:160. doi: 10.3389/fimmu.2014.00160. eCollection 2014.

15.

Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.

Wojtuszkiewicz A, Schuurhuis GJ, Kessler FL, Piersma SR, Knol JC, Pham TV, Jansen G, Musters RJ, van Meerloo J, Assaraf YG, Kaspers GJ, Zweegman S, Cloos J, Jimenez CR.

Mol Cell Proteomics. 2016 Apr;15(4):1281-98. doi: 10.1074/mcp.M115.052944. Epub 2016 Jan 22.

16.

Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.

Feller N, Kelder A, Westra G, Ossenkoppele GJ, Schuurhuis GJ.

Cytometry B Clin Cytom. 2008 Jan;74(1):9-16.

17.
18.

Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia.

Akashi K, Harada M, Shibuya T, Eto T, Takamatsu Y, Teshima T, Niho Y.

Blood. 1991 Jul 1;78(1):197-204.

19.

Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.

Bradbury DA, Zhu YM, Russell NH.

Leuk Lymphoma. 1997 Jan;24(3-4):221-8. Review.

PMID:
9156652
20.

Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression.

Bradbury DA, Aldington S, Zhu YM, Russell NH.

Br J Haematol. 1996 Sep;94(4):671-5.

PMID:
8826891

Supplemental Content

Support Center